Although the cancer cells did not grow differently in culture, tumors carrying the fusion grew significantly faster than controls (Figure 6E and F) upon grafting on mice, suggesting that the ZDHHC17-LNCKB.11978 fusion does indeed have oncogenic activity. This evidence concerns the gene ZDHHC17 and cancer.